Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase-Reference-Cited by-同舟云学术

Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase

Published:2006-01 Issue:9 Volume:47 Page:1768-1773
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Olsson-Strömberg Ulla,Höglund Martin,Björkholm Magnus,Braide Inger,Carlson Karin,Gahrton Gösta,Grimfors Gunnar,Hast Robert,Lerner Rickard,Linder Olle,Ljungman Per,Löfvenberg Eva,Malm Claes,Nilsson Per-Gunnar,Paul Christer,Rödjer Stig,Stenke Leif,Tidefeldt Ulf,Turesson Ingemar,Uden Ann-Marie,Wahlin Anders,Vilen Lars,Winqvist Ingemar,Zettervall Olle,Öberg Gunnar,Simonsson Bengt,(For The Swedish Cml Group)

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190600611117

Reference39 articles.

1. Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups

2. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

3. Optimizing Treatment for Chronic Myeloid Leukemia

4. Long-Term Follow-Up of the Italian Trial of Interferon- Versus Conventional Chemotherapy in Chronic Myeloid Leukemia

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Success Story of Targeted Therapy in Chronic Myeloid Leukemia: A Population-Based Study of Patients Diagnosed in Sweden From 1973 to 2008;Journal of Clinical Oncology;2011-06-20

2. Current Awareness in Hematological Oncology;Hematological Oncology;2007

3. Autologous stem cell collection and autograft for patients with chronic myeloid leukemia in the era of ABL kinase inhibitors: Back to the bench;Leukemia & Lymphoma;2006-01